null - FindTrial

lNA - LOSTINDIAB

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2022-000297-26-FR

Enrollment

150

Registered

2022-03-01

Start date

2022-05-03

Completion date

Unknown

Last updated

2025-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: ACTRAPID 100 UI/ml solution injectable en flacon Pharmaceutical Form: Solution for injection in vial INN or Proposed INN: INSULIN HUMAN CAS Number: 11061-68-0 Concentration unit: IU/ml int

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: NA Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 128 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 22

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

Measure	Time frame
Main Objective: NA;Secondary Objective: NA;Primary end point(s): NA;Timepoint(s) of evaluation of this end point: NA	—

Secondary

Measure	Time frame
Secondary end point(s): NA;Timepoint(s) of evaluation of this end point: NA	—

Countries

France

Contacts

Public ContactSEYMOUR-INAMO

APHP

karine.seymour@aphp.fr+3301 44 84 17 42

Outcome results